Terns Pharmaceuticals, Inc. (TERN) Dividend History

Terns Pharmaceuticals, Inc. is a biotechnology company focused on developing innovative therapies for metabolic and liver diseases. Based in the United States, the company leverages precision medicine and advanced research techniques to create targeted treatments aimed at unmet medical needs in conditions such as non-alcoholic steatohepatitis (NASH) and related metabolic disorders.

1065 East Hillsdale Blvd., Suite 100, Foster City, CA, 94404
Phone: 650-525-5535 EXT.101
Website: https://www.ternspharma.com

Dividend History

Terns Pharmaceuticals, Inc. currently does not pay dividends

Company News

  • Terns Pharmaceuticals has a promising GLP-1 weight-loss drug that could compete with treatments from Novo Nordisk and Eli Lilly. However, the company is still in early stages and faces risks, including the need for ongoing stock offerings to fund its cash-burning operations.

    The Motley Fool
    Featured Companies: LLY
  • Terns Pharmaceuticals, a clinical-stage biopharmaceutical company, announced the pricing of its upsized underwritten public offering of 11,919,048 shares of its common stock at $10.50 per share, as well as pre-funded warrants to purchase 2,380,952 shares. The company intends to use the net proceeds to fund research, clinical trials, and development of its key product candidates.

    GlobeNewswire Inc.
  • Terns Pharmaceuticals, Inc. (TERN) outperforms the industry year to date on encouraging pipeline progress of its oncology candidate.

    Zacks Investment Research
    Featured Companies: ALXO LGND
  • Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results. Take-Two reported third-quarter total net bookings of $1.34 billion, down 3% year-over-year. The company also revised its 2024 net bookings forecast to $5.25 billion and $5.3 billion, down from $5.45 billion and $5.55 billion earlier. Take-Two Interactive Software shares dipped 8.8% to $154.69 on Friday. Here are some other stocks moving in today's mid-day session. Gainers Sunworks, Inc. (NASDAQ: SUNW) shares jumped 267% to $0.1990. Sunworks and three subsidiaries recently made the decision to cease operations and filed for Chapter 7 bankruptcy in the United States Bankruptcy Court for the District of Delaware. TOP Financial Group Limited (NASDAQ: TOP) gained 87.55% to $6.13. NanoString Technologies, Inc. (NASDAQ: NSTG) shares climbed 66% to $0.1932 after the company disclosed completion of financing to support restructuring process. Intelligent Bio Solutions Inc. (NASDAQ: INBS) jumped 47.3% to $4.24 following second-quarter results. TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares climbed 46% to $1.6099 after jumping over 16% on Thursday. Intelligent Living Application Group Inc. (NASDAQ: ILAG) gained 45.5% to $0.6851 after surging around 24% on Thursday. Green Giant Inc. (NASDAQ: GGE) shares rose 44.4% to $0.0535 after gaining 25% on Thursday. Better Choice Company Inc. (NYSE: BTTR) gained 35% to $0.2379. Better Choice acquired Aimia Pet Healthco. Masonite International Corporation (NYSE: DOOR) surged 34.5% to $129.99 after Owens Corning announced it will acquire the company for $3.9 billion. Cloudflare, Inc. (NYSE: NET) rose 23.5% to $111.49 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter guidance. CleanSpark, Inc. (NASDAQ: CLSK) shares gained 22% to $12.81 after the company reported a year-over-year increase in first-quarter GAAP EPS and ...

    Benzinga
  • Madrigal Pharmaceuticals' resmetirom is a leading treatment candidate for the advanced form of fatty liver disease.

    MarketWatch
    Featured Companies: ETNB LLY MDGL ROG VKTX XBI XPH
Page data last updated 07/22/2025 16:34:10 UTC